Facilitated By

San Antonio Medical Foundation

SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Kaushal, Deepak
Funded by
National Institutes of Health
Research Start Date
Status
Active

The major goal is to develop a delta-sigH -based human TB vaccine candidate that could eventually advance to clinical development. Role: PI

Collaborative Project
Basic Research
Disease Modeling
Infectious Disease